4D Pharma PLC ADR (LBPS) Financials

$1.65

$0.00 (0.00%)

As on 28-Jul-2022 09:30EDT

Market cap

$37 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Income Statement (£ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Operating Revenue	0.72	0.53	0.21	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	37.52	31.08	30.83	29.12	20.36	--
Operating Profit (EBIT)	-37.26	-41.13	-41.47	-36.00	-24.35	-13.09
Other Income	--	--	--	--	--	--
Profit before Tax	-31.96	-30.35	-29.43	-28.44	-23.99	-11.71
Provision for Tax	-0.02	-4.38	-5.36	-4.75	-3.54	-1.84
Profit after Tax (Net Income)	-31.94	-25.96	-24.07	-23.69	-20.45	-9.86
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-31.94	-30.50	-30.33	-23.69	-20.45	--

Liabilities (£ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Shareholder's Funds	32.42	27.97	22.34	45.76	69.79	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	19.76	1.00	2.01	1.67	2.97	1.74
Current Liabilities	6.62	6.45	6.26	5.18	4.98	4.94
Total Liabilities	58.79	35.42	30.61	52.61	77.74	93.16

Assets (£ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Non-Current Assets	24.29	18.70	19.34	19.45	19.94	18.18
Current Assets	34.50	16.73	11.27	33.16	57.80	74.98
Total Assets	58.79	35.42	30.61	52.61	77.74	93.16
Total Debt*	12.80	1.06	1.11	0.03	0.04	--
Net Current Assets	27.88	10.27	5.01	27.98	52.82	--

Cashflow (£ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Cash From Operating Activities	-37.92	-22.67	-21.56	-22.94	-17.19	-13.53
Cash Flow from Investing Activities	-0.28	-0.23	12.28	27.14	0.41	--
Cash from Financing Activities	46.42	27.79	-0.38	-0.01	-0.01	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Adjusted EPS (£)	--	-12.98	--	--	--	--
Cash EPS (£)	--	-12.38	--	--	--	--
Adjusted Book Value (£)	--	13.99	--	--	--	--
Dividend per Share (£)	--	--	--	--	--	--
Cash Flow per Share (£)	--	-11.34	--	--	--	--
Free Cash Flow per Share (£)	--	-11.43	--	--	--	--

Profitability Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
ROCE (%)	-86.03	-98.94	-69.51	-40.98	-58.56	--
ROE (%)	-105.78	-103.21	-70.67	-41.00	-29.30	--
ROA (%)	-67.80	-78.64	-57.84	-36.35	-23.93	-10.35
EBIT Margin (%)	-4,370.33	-5,650.37	-13,702.37	--	--	--
Net Margin (%)	-4,448.19	-4,861.99	-11,405.69	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Revenue Growth (%)	0.34	1.53	--	--	--	--
EBIT Growth (%)	-4.00	-4.36	-2.93	-38.30	-83.39	-10.12
Net Profit Growth (%)	-23.01	-7.88	-1.59	-15.87	-107.29	-30.69
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debt to Equity	0.39	0.04	0.05	0.00	0.00	--
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	--
Current Ratio	5.21	2.59	1.80	6.40	11.60	15.19
Quick Ratio	5.16	2.55	1.77	6.35	11.55	15.14
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debtors to sales (%)	407.33	1,135.21	2,901.42	--	--	--
Asset Turnover	0.02	0.02	0.01	--	--	--
Receivable days	2,285.78	4,166.86	9,966.48	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--